Literature DB >> 24641205

Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDR.

Emmanuel Elanga Ndille1, Audrey Dubot-Pérès, Souleymane Doucoure, François Mouchet, Sylvie Cornelie, Bounpone Sidavong, Florence Fournet, Franck Remoue.   

Abstract

OBJECTIVE: Using human IgG antibody response to the Aedes Nterm-34 kDa salivary peptide as an indicator of human exposure to Aedes bites in surveying exposed populations from areas at risk of dengue virus (DENV) transmission in urban settings of Vientiane city, Lao PDR.
METHODS: Enzyme-linked immunosorbent assay tests were performed to measure the IgG response to Nterm-34 kDa peptide in blood samples collected within a flavivirus seroprevalence survey carried out in 2006 including 3558 randomly selected individuals. The level of IgG response to the Nterm-34 kDa peptide in individuals was analysed in relation to the level of urbanisation of the individual's residence, areas that presented significant differences in the prevalence of recent DENV infection.
RESULTS: No differences were observed in the anti-Nterm-34 kDa IgG level between DENV-positive and DENV-negative individuals. However, the level of specific IgG response was higher among individuals living in slightly urbanised neighbourhoods than among those in more highly urbanised areas (P < 0.0001). Interestingly, a similar pattern had already been observed concerning the prevalence of recent DENV infection in the same populations.
CONCLUSION: The results of this retrospective study indicate that the evaluation of human IgG response to the Aedes Nterm-34 kDa salivary peptide could be a useful indicator to identify places with risk of dengue virus transmission in urban endemic areas.
© 2014 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Aedes bites; Vientiane; dengue risk; residential neighbourhoods; salivary biomarker; spatial distribution

Mesh:

Substances:

Year:  2014        PMID: 24641205     DOI: 10.1111/tmi.12280

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  17 in total

1.  Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia.

Authors:  Jessica E Manning; Sophana Chea; Daniel M Parker; Jennifer A Bohl; Sreyngim Lay; Allyson Mateja; Somnang Man; Sreynik Nhek; Aiyana Ponce; Sokunthea Sreng; Dara Kong; Soun Kimsan; Claudio Meneses; Michael P Fay; Seila Suon; Rekol Huy; Chanthap Lon; Rithea Leang; Fabiano Oliveira
Journal:  J Infect Dis       Date:  2022-10-17       Impact factor: 7.759

2.  An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.

Authors:  Berlin Londono-Renteria; Papa M Drame; Thomas Weitzel; Reinaldo Rosas; Crystal Gripping; Jenny C Cardenas; Marcela Alvares; Dawn M Wesson; Anne Poinsignon; Franck Remoue; Tonya M Colpitts
Journal:  Parasit Vectors       Date:  2015-10-13       Impact factor: 3.876

3.  Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.

Authors:  Emmanuel Elanga Ndille; Souleymane Doucoure; Anne Poinsignon; François Mouchet; Sylvie Cornelie; Eric D'Ortenzio; Jean Sébastien DeHecq; Franck Remoue
Journal:  PLoS Negl Trop Dis       Date:  2016-12-01

4.  Evaluation of Human Exposure to Aedes Bites in Rubber and Palm Cultivations Using an Immunoepidemiological Biomarker.

Authors:  Céline Mabot Yobo; Cécile Agnimou Malanfoua Sadia-Kacou; Maurice Akré Adja; Emmanuel Elanga-Ndille; André Barembaye Sagna; Négnorogo Guindo-Coulibaly; Anne Poinsignon; Franck Remoue; Benjamin Guibéhi Koudou
Journal:  Biomed Res Int       Date:  2018-08-09       Impact factor: 3.411

Review 5.  Salivary Biomarkers in the Control of Mosquito-Borne Diseases.

Authors:  Souleymane Doucoure; Papa Makhtar Drame
Journal:  Insects       Date:  2015-11-17       Impact factor: 2.769

6.  Serosurvey of Human Antibodies Recognizing Aedes aegypti D7 Salivary Proteins in Colombia.

Authors:  Berlin L Londono-Renteria; Heman Shakeri; Paula Rozo-Lopez; Michael J Conway; Natasha Duggan; Majid Jaberi-Douraki; Tonya M Colpitts
Journal:  Front Public Health       Date:  2018-05-18

7.  Assessing dengue transmission risk and a vector control intervention using entomological and immunological indices in Thailand: study protocol for a cluster-randomized controlled trial.

Authors:  Hans J Overgaard; Chamsai Pientong; Kesorn Thaewnongiew; Michael J Bangs; Tipaya Ekalaksananan; Sirinart Aromseree; Thipruethai Phanitchat; Supranee Phanthanawiboon; Benedicte Fustec; Vincent Corbel; Dominique Cerqueira; Neal Alexander
Journal:  Trials       Date:  2018-02-20       Impact factor: 2.279

8.  Current vector research challenges in the greater Mekong subregion for dengue, Malaria, and Other Vector-Borne Diseases: A report from a multisectoral workshop March 2019.

Authors:  Rebecca C Christofferson; Daniel M Parker; Hans J Overgaard; Jeffrey Hii; Gregor Devine; Bruce A Wilcox; Vu Sinh Nam; Sazaly Abubakar; Sebastien Boyer; Kobporn Boonnak; Stephen S Whitehead; Rekol Huy; Leang Rithea; Tho Sochantha; Thomas E Wellems; Jesus G Valenzuela; Jessica E Manning
Journal:  PLoS Negl Trop Dis       Date:  2020-07-30

Review 9.  New Immuno-Epidemiological Biomarker of Human Exposure to Aedes Vector Bites: From Concept to Applications.

Authors:  André B Sagna; Mabo C Yobo; Emmanuel Elanga Ndille; Franck Remoue
Journal:  Trop Med Infect Dis       Date:  2018-08-01

10.  Serological biomarker for assessing human exposure to Aedes mosquito bites during a randomized vector control intervention trial in northeastern Thailand.

Authors:  Benedicte Fustec; Thipruethai Phanitchat; Sirinart Aromseree; Chamsai Pientong; Kesorn Thaewnongiew; Tipaya Ekalaksananan; Dominique Cerqueira; Anne Poinsignon; Eric Elguero; Michael J Bangs; Neal Alexander; Hans J Overgaard; Vincent Corbel
Journal:  PLoS Negl Trop Dis       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.